FDA Import Refusal 799-2996708-9/11/1 — Sanofi Aventis Us Inc
The FDA refused shipment 799-2996708-9/11/1 from Sanofi Aventis Us Inc (United States) on Sep 19, 2019. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Sep 19, 2019
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA31 GLIMEPIRIDE (ANTI-DIABETIC)
- Charges
- 75